Jul. 5 at 1:43 PM
$ICU This is the potential X-Factor, both bears and bulls assume some degree of dilution is needed to get to full approval in adults, but an OUS partnership would provide enough capital in upfront payments to alleviate the need for dilution. If you took dilution off the table, the share price would all but go VERTICAL. Even a single country oulicense would do it... I model that Japan or China deal would include upfront payments in the range of
$15M to
$30M each... the argument against outlicensing now is that your bargaining power increases with each new data point and US progress... so waiting will bring better terms... if it was me, I would lock in one OUS market now and wait for leverage in other markets
